Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

10X Genomics Inc (TXG)

10X Genomics Inc (TXG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,716,608
  • Shares Outstanding, K 109,799
  • Annual Sales, $ 298,850 K
  • Annual Income, $ -542,730 K
  • 60-Month Beta 1.29
  • Price/Sales 67.41
  • Price/Cash Flow N/A
  • Price/Book 27.07
Trade TXG with:

Options Overview

Details
  • Implied Volatility 57.68%
  • Historical Volatility 40.31%
  • IV Percentile 62%
  • IV Rank 52.99%
  • IV High 71.70% on 03/04/21
  • IV Low 41.89% on 08/26/20
  • Put/Call Vol Ratio 1.13
  • Today's Volume 17
  • Volume Avg (30-Day) 342
  • Put/Call OI Ratio 0.47
  • Today's Open Interest 8,096
  • Open Int (30-Day) 7,625

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.26
  • Number of Estimates 3
  • High Estimate -0.24
  • Low Estimate -0.27
  • Prior Year -0.41
  • Growth Rate Est. (year over year) +36.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
166.00 +8.28%
on 07/15/21
208.99 -13.99%
on 06/29/21
-9.98 (-5.26%)
since 06/25/21
3-Month
128.15 +40.27%
on 05/11/21
208.99 -13.99%
on 06/29/21
-18.95 (-9.54%)
since 04/27/21
52-Week
92.54 +94.24%
on 08/12/20
208.99 -13.99%
on 06/29/21
+83.94 (+87.61%)
since 07/27/20

Most Recent Stories

More News
Bio-Rad and 10x Genomics Announce Settlement to Resolve Multiple Litigations

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Bio-Rad and 10x Genomics, Inc. (Nasdaq: TXG) have reached...

BIO : 702.79 (+2.51%)
TXG : 179.75 (+0.10%)
10x Genomics Signs Global Patent Cross License Agreement with Bio-Rad

Agreement to Cross License Single Cell Technologies Ends all Ongoing Legal Disputes

TXG : 179.75 (+0.10%)
4 Overvalued Healthcare Stocks to Avoid

Despite unprecedented advancements in the healthcare industry, investors are currently shifting their focus toward outdoor stocks to benefit from the fast-paced economic reopening. In-part because of this...

NVCR : 180.36 (-1.92%)
TXG : 179.75 (+0.10%)
GDRX : 31.69 (+1.80%)
DOCS : 59.43 (-10.63%)
10x Genomics Introduces New Chromium X Series for Single Cell Analysis

Building on its industry leading position in single cell analysis, 10x Genomics (NASDAQ: TXG) today announced commercial availability of its new Chromium X Series, a next-generation platform for single...

TXG : 179.75 (+0.10%)
10x Genomics to Report Second Quarter Financial Results on August 4, 2021

10x Genomics (Nasdaq: TXG) today announced it will report financial results for the second quarter 2021 after market close on Wednesday, August 4th, 2021. The company's management will webcast a corresponding...

TXG : 179.75 (+0.10%)
Genuity Science Awarded Designation as a 10x Genomics Certified Service Provider in Single Cell Immune Profiling

/PRNewswire/ -- , a genomics data, analytics and insights organization, today announced its participation with leading life science technology company,  (Nasdaq: TXG) through 10x Genomics' Certified...

TXG : 179.75 (+0.10%)
High-Growth Stocks Come Back Into Investors' Favor

The short-term bottom for next-generation enterprises is in, and high multiple stocks are returning to investors' favor.

TSLA : 644.78 (-1.95%)
SPLK : 140.55 (-0.76%)
PATH : 59.83 (-4.10%)
SHOP : 1,555.10 (-1.72%)
TWLO : 387.48 (-2.70%)
ARKK : 118.62 (-2.45%)
CRSP : 117.43 (-1.50%)
CRWD : 257.84 (-2.64%)
TXG : 179.75 (+0.10%)
10x Genomics Unlocks Whole Transcriptome Analysis in FFPE Tissues With New Visium Assay, Now Shipping

10x Genomics, Inc. (Nasdaq: TXG) today announced it is shipping its new Visium Spatial Gene Expression for FFPE (formalin-fixed and paraffin-embedded) assay. The offering gives researchers access to the...

TXG : 179.75 (+0.10%)
Strength Seen in 10x Genomics (TXG): Can Its 3.9% Jump Turn into More Strength?

10x Genomics (TXG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

TXG : 179.75 (+0.10%)
10x Genomics to Participate in Upcoming June Investor Conferences

10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating virtually in the following investor conferences:

TXG : 179.75 (+0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.

See More

Key Turning Points

3rd Resistance Point 189.62
2nd Resistance Point 185.00
1st Resistance Point 182.37
Last Price 179.75
1st Support Level 175.12
2nd Support Level 170.50
3rd Support Level 167.87

See More

52-Week High 208.99
Last Price 179.75
Fibonacci 61.8% 164.51
Fibonacci 50% 150.76
Fibonacci 38.2% 137.02
52-Week Low 92.54

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar